Cancer-associated ischemic stroke is associated with elevated d-dimer and fibrin degradation product levels in acute ischemic stroke with advanced cancer

Geriatrics and Gerontology International

Volumn 12, Issue 3, 2012, Pages 468-474

  Kono, Tomoyuki ^a   Ohtsuki, Toshiho ^a   Hosomi, Naohisa ^a   Takeda, Ikuko ^a   Aoki, Shiro ^a   Sueda, Yoshimasa ^a   Ishihara, Kayoko ^a   Nakamura, Takeshi ^a   Yamawaki, Takemori ^a   Matsumoto, Masayasu ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Cancer; d dimer; Fibrin degradation product; Ischemic stroke

Indexed keywords

D DIMER; FIBRIN; HEMOGLOBIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BRAIN CANCER; BRAIN ISCHEMIA; CANCER PATIENT; CANCER STAGING; DISEASE ASSOCIATION; FEMALE; FIBRINOLYSIS; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; DIABETES MELLITUS, TYPE 2; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOPLASMS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; STATISTICS, NONPARAMETRIC; STROKE;

EID: 84862794927     PISSN: 14441586     EISSN: 14470594     Source Type: Journal    
DOI: 10.1111/j.1447-0594.2011.00796.x     Document Type: Article

References (15)

1. Graus F, Rogers LR, Posner JB. Cerebrovascular complications in patients with cancer. Medicine (Baltimore) 1985; 64: 16-35.
2. Hiatt BK, Lentz SR. Prothrombotic states that predispose to stroke. Curr Treat Options Neurol 2002; 4: 417-425.
3. Rogers LR. Cerebrovascular complications in cancer patients. Neurol Clin 2003; 21: 167-192.
4. Cestari DM, Weine DM, Panageas KS, Segal AZ, DeAngelis LM. Stroke in patients with cancer: incidence and etiology. Neurology 2004; 62: 2025-2030.
5. Seok JM, Kim SG, Kim JW etal. Coagulopathy and embolic signal in cancer patients with ischemic stroke. Ann Neurol 2010; 68: 213-219.
6. Jabaudon D, Sztajzel J, Sievert K, Landis T, Sztajzel R. Usefulness of ambulatory 7-day ECG monitoring for the detection of atrial fibrillation and flutter after acute stroke and transient ischemic attack. Stroke 2004; 35: 1647-1651.
7. Lister TA, Crowther D, Sutcliffe SB etal. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: cotswolds meeting. J Clin Oncol 1989; 7: 1630-1636.
8. Adams HP Jr, Bendixen BH, Kappelle LJ etal. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24: 35-41.
9. Kim SG, Hong JM, Kim HY etal. Ischemic stroke in cancer patients with and without conventional mechanisms: a multicenter study in Korea. Stroke 2010; 41: 798-801.
10. Dutta T, Karas MG, Segal AZ, Kizer JR. Yield of transesophageal echocardiography for nonbacterial thrombotic endocarditis and other cardiac sources of embolism in cancer patients with cerebral ischemia. Am J Cardiol 2006; 97: 894-898.
11. Oberndorfer S, Nussgruber V, Berger O, Lahrmann H, Grisold W. Stroke in cancer patients: a risk factor analysis. J Neurooncol 2009; 94: 227-226.
12. Uemura J, Kimura K, Sibazaki K, Inoue T, Iguchi Y, Yamashita S. Acute stroke patients have occult malignancy more often than expected. Eur Neurol 2010; 64: 140-144.
13. Amico L, Caplan LR, Thomas C. Cerebrovascular complications of mucinous cancers. Neurology 1989; 39: 522-526.
14. Towfighi J, Simmonds MA, Davidson EA. Mucin and fat emboli in mucinous carcinomas. Cause of hemorrhagic cerebral infarcts. Arch Pathol Lab Med 1983; 107: 646-649.
15. Robitaille Y. Hemorrhagic infarcts caused by mucin emboli mimicking brain purpura. Cancer 1980; 46: 1608-1611.